HIGHLIGHTS
- who: Xiaoyan Liu from the Foundation (IRCCS), Italy Center for Neurological Diseases, Beijing Tiantan, Capital Medical University, Beijing, China, Department of have published the article: LC-MS-Based Urine Metabolomics Analysis for the Diagnosis and Monitoring of Medulloblastoma, in the Journal: (JOURNAL)
- what: The aim of this study was to utilize urine metabolomics to explore potential biomarkers for the detection of MB. The authors comprehensively characterized the urine metabolomics of MB patients, including healthy subjects, patients with malignant brain tumors and patients with benign brain diseases. In the present study, MB-associated urinary metabolite changes . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.